Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Cipla Limited

Market Cap 1,117B 11.67B 10.13B 9.34B 8.75B 16.34B 16.68B 111B 43.11B 539B 43.81B 42.87B 1,873B P/E Ratio 2027 *
26.7x
P/E Ratio 2028 * 21.8x
Enterprise Value 1,019B 10.64B 9.23B 8.51B 7.97B 14.9B 15.21B 102B 39.31B 491B 39.94B 39.08B 1,708B EV / Sales 2027 *
3.28x
EV / Sales 2028 * 2.87x
Free-Float
65.43%
Yield 2027 *
0.9%
Yield 2028 * 1.02%
1 day+0.46%
1 week+0.59%
Current month-1.26%
1 month+2.69%
3 months+3.73%
6 months-7.22%
Current year-8.47%
1 week 1,371.1
Extreme 1371.1
1,406.1
1 month 1,274.7
Extreme 1274.7
1,444.5
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 955.15
Extreme 955.15
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
President - 18/05/2026
Director of Finance/CFO - 16/08/2022
Director TitleAgeSince
Chairman 89 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Date Insider Type Main position Quantity % Market Cap.
22/08/24Sell 2,000 0.0002%
14/08/24Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%+0.59%-8.44%+42.72% 11.68B
+0.44%+0.32%+6.24%+82.35% 44.99B
-0.44%-7.89%+40.02%+89.26% 33.69B
+0.69%+2.72%+12.64%+117.80% 11.6B
+1.27%+0.39%+36.17%+125.55% 8.94B
-1.44%-1.94%+15.12%+39.86% 7.01B
+0.00%-1.36%+32.74%+237.16% 6.35B
+0.61%+3.68%+45.01%-16.20% 6.51B
-0.45%-3.68%-38.58%-6.82% 5.15B
+2.23%+7.31%+22.01%+116.03% 4.03B
Average +0.38%-0.34%+16.29%+82.77% 13.99B
Weighted average by Cap. +0.24%-1.62%+17.85%+84.41%

Financials

2027 *2028 *
Net sales 311B 3.24B 2.82B 2.59B 2.43B 4.54B 4.64B 30.95B 11.98B 150B 12.18B 11.92B 521B 346B 3.62B 3.14B 2.89B 2.71B 5.07B 5.17B 34.52B 13.37B 167B 13.58B 13.29B 581B
Net income 41.87B 437M 379M 350M 328M 612M 625M 4.17B 1.62B 20.18B 1.64B 1.61B 70.18B 51.21B 535M 464M 428M 401M 749M 765M 5.1B 1.98B 24.69B 2.01B 1.96B 85.83B
Net Debt -98.65B -1.03B -894M -824M -772M -1.44B -1.47B -9.83B -3.81B -47.55B -3.87B -3.78B -165B -125B -1.3B -1.13B -1.04B -977M -1.83B -1.86B -12.44B -4.82B -60.19B -4.9B -4.79B -209B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
11/06/26 1,383.30 +0.46% 654,474
10/06/26 1,377.00 +0.04% 962,642
09/06/26 1,376.50 -0.82% 1,419,845
08/06/26 1,387.90 -0.96% 669,481
05/06/26 1,401.30 +0.19% 1,050,391
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,383.30INR
Average target price
1,456.73INR
Spread / Average Target
+5.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!